Upload
lynna
View
32
Download
0
Tags:
Embed Size (px)
DESCRIPTION
Project HEART: Expanding Access, Extending Lives. Presented by Denis Tindyebwa, MD; EGPAF Regional Director Pediatric Care and Treatment . Project HEART: Program update. Expanded access Geographical coverage Increased enrollment Program outcomes Increasing focus on children - PowerPoint PPT Presentation
Citation preview
Project HEART: Expanding Access, Extending Lives
Presented by Denis Tindyebwa, MD; EGPAF Regional Director Pediatric Care and
Treatment
Project HEART: Program update• Expanded access
– Geographical coverage– Increased enrollment
• Program outcomes• Increasing focus on children• PMTCT Linkages• Hope for the future
Elizabeth Glaser Pediatric AIDS FoundationMission:
The Elizabeth Glaser Pediatric AIDS Foundation seeks to prevent pediatric HIV infection and to eradicate pediatric AIDS
through research, advocacy, and prevention and treatment programs.
Project HEART supports activities in five countries
Côte d’IvoireMozambiqueSouth AfricaTanzaniaZambia
Côte d’Ivoire
Zambia
Tanzania
South Africa
Mozambique
Project HEART Countries
Sites in Project HEART Countries
0
20
40
60
80
100
120
140
160
Quarter
Num
ber o
f site
s
Cote d'Ivoire Mozambique South Africa Tanzania Zambia
Project HEART: Number of care and treatment sites reporting by quarter since the beginning of the program, by country
Doubling expansionevery year
Project HEART: Number of Persons Ever on Care and ART by quarter, over time
1964345329
57256 6781485648
96880116433
138497 138531
176514
204279227017
252263
281117
1923131279
7970696064
117075133485
166136188321
219464
259720 263505
323805
374680
416116
461152
509736
36712150978565
310163
40135
568380
0
100000
200000
300000
400000
500000
600000
2004Q4
2005Q1
2005Q2
2005Q3
2005Q4
2006Q1
2006Q2
2006Q3
2006Q4
2007Q1
2007Q2
2007Q3
2007Q4
2008Q1
2008Q2
2008Q3
2008Q4
2009Q1
Total Cum ART Total Cum Care
Doubling ART Initiation every year
Patients New on ART during the quarter, over time
New on ART during the quarter
0
2000
4000
6000
8000
10000
12000
14000
1600020
04 Q
4
2005
Q1
2005
Q2
2005
Q3
2005
Q4
2006
Q1
2006
Q2
2006
Q3
2006
Q4
2007
Q1
2007
Q2
2007
Q3
2007
Q4
2008
Q1
2008
Q2
2008
Q3
2008
Q4
2009
Q1
Quarter
Cote d'Ivoire
Mozambique
South Africa
Tanzania
Zambia
1. Number of patients living with HIV, ever enrolled in long-term clinical care and support programs.
2. Of those enrolled, number of patients started on ARV therapy.
CUMULATIVE data from March 1, 2004 through March 30, 2009
Project HEARTCumulative Patient Enrollment
Country
HIV Palliative Care1 Antiretroviral Treatment2
Children Adults Total Children Adults Total
Zambia13,641 (7.3%)
172,853
186,494
8,387 (7.0%) 111,109
119,496
Cote d'Ivoire
4,755 (4.5%)
100,447
105,202
1,968 (3.9%) 48,084 50,052
South Africa
13,420 (9.4%)
128,743
142,163
8,926 (10.3%) 77,333 86,259
Tanzania7,862 (9.5%) 75,241 83,103
3,212 (8.5%) 34,757 37,969
Mozambique
3,457 (6.7%) 47,961 51,418
1,149 (7.0%) 15,238 16,387
Total43,135 (7.6%)
525,245
568,380
23,642 (7.6%) 286,521
310,163
Project HEART Cumulative Patient Enrollment: End of Q1 2009
0
100000
200000
300000
400000
500000
600000
Cote d'Ivoire Mozambique South Africa Tanzania Zambia Total
Total Care
Total ART
Project HEART Patients currently in Program
All patients CURRENTLY on care and treatment on March 30, 2009
Country
HIV Palliative Care1 Antiretroviral Therapy2
Children Adults Total Children Adults Total
Zambia6,397
(7.1%) 83,962 90,3594,898 (6.5%) 70,449 75,347
Cote d'Ivoire
1,753 (4.6%) 36,105 37,858
1,317 (3.9%) 32,410 33,727
South Africa
9,137 (10.5%) 78,227 87,364
8,146 (11.1%) 65,421 73,567
Tanzania6,446 (9.7%) 60,093 66,539
2,593 (8.3%) 28,774 31,367
Mozambique
1,900 (7.8%) 22,368 24,268
917 (7.5%) 11,290 12,207
Total25,633 (8.4%)
280,755
306,388
17,871 (7.9%)
208,344
226,215
1. Number of HIV-positive patients who received care anytime January 1- March 30, 2009.
2. Number of patients on ART on March 30th 2009.
Project HEART Patients currently in Program: Q1 2009
0
50000
100000
150000
200000
250000
300000
350000
Cote d'Ivoire Mozambique South Africa Tanzania Zambia Total
Total on Care
Total on ART
13Reasons for Attrition All Patients and Among Adults , Q1 2009
Stopped ART3%
Transferred out25%
Death20%
Lost to follow-up46%
Unknown7%
Adults
Stopped ART2%
Transferred out25%
Death20%
Lost to follow-up45%
Unknown7%
All Patients
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
Cote d`Ivoire Mozambique South Africa Tanzania Zambia Total
Country
Percent of current care who received CTX during quarter, Jan-Mar 09
0-14 15+
Percent of Persons in Care Receiving Cotrimoxazole, Q1 2009
Percentage of patients on ART who are on first line regimens:
End of Q1 2009, by age group
94.2 93.8
100100
98.198.398.8
99.7
96.2
95.1
90
91
92
93
94
95
96
97
98
99
100
Cote d'Ivoire Mozambique South Africa Tanzania Zambia
Children
Adults
CD4 Cohort Data: Median CD4 at Baseline and 6 Mos, Q1 2009
Cote d'Ivoire Mozambique South Africa Tanzania Zambia0
50
100
150
200
250
300
350
400
450
500
550
600
178156
109152 151
359
298
244
284 284
CD4
coun
t
93.988.0
76.1 74.3
90.1
60.161.9
66.2
61.9
8.6
0
10
20
30
40
50
60
70
80
90
100
Cote d'Ivoire Mozambique South Africa Tanzania Zambia
Countries
Perc
enta
ge o
f pat
ient
s
Baseline 6-month follow-up
Percentage of Patients in 6-month Cohort with CD4 Counts at Baseline and at the end of the Follow-Up Period, Q1 2009
Number of children currently on ART during Q3 2008, Q4 2008, and Q1 2009
8,146
6,275
626
4,557
2,088
1,165 784
7,300
4,897
2,213
1,270 1,317 917
4,898
2,593
0
1,000
2,000
3,000
4,000
5,000
6,000
7,000
8,000
9,000
Cote d'Ivoire Mozambique South Africa Tanzania Zambia
Countries
Num
ber o
f chi
ldre
n
Jul.-Sept. 2008 Oct .-Dec. 2008 Jan.-Mar. 2009
Percentage of patients currently on ART who were children during Q3 2008, Q4 2008, and Q1 2009
6.8 6.96.5
11.5
8.9
6.3
3.9
11.0
6.9
8.4
4.0
11.1
7.58.3
3.9
0.0
2.0
4.0
6.0
8.0
10.0
12.0
14.0
Cote d'Ivoire Mozambique South Africa Tanzania Zambia
Countries
Perc
enta
ge o
f chi
ldre
n
Jul.-Sept. 2008 Oct.-Dec. 2008 Jan.-Mar. 2009
Children newly started on ART during the quarter
Children newly started on ART during the quarter
455594 544 520
718 714
2,149
1,029
1,4071,548
1,109
1,488
1,7031,786 1,749
2,285
2,508
0
500
1000
1500
2000
2500
3000
2005Q1
2005Q2
2005Q3
2005Q4
2006Q1
2006Q2
2006Q3
2006Q4
2007Q1
2007Q2
2007Q3
2007Q4
2008Q1
2008Q2
2008Q3
2008Q4
2009Q1
Num
ber o
f chi
ldre
n ne
wly s
tarted
on
ART
Children started on ART
Stopped ART2%
Transferred out31%
Death20%
Lost to follow-up42%
Unknown6%
All children (0-14 years)Stopped ART
2% Transferred out16%
Death28%
Lost to follow-up51%
Unknown3%
Children (0-1 years)
Stopped ART2%
Transferred out32%
Death18%
Lost to follow-up41%
Unknown6%
Children (2-4 years)
Stopped ART2%
Transferred out36%
Death18%
Lost to follow-up39%
Unknown6%
Children (5-14 years)
Reasons for Attrition Among Children by Age Group, Q1 2009
Stopped ART2%
Transferred out31%
Death20%
Lost to follow-up42%
Unknown6%
All children (0-14 years)
Reasons for Attrition Among Children and Adults, Q1 2009
Stopped ART3%
Transferred out25%
Death20%
Lost to follow-up46%
Unknown7%
Adults
Percent distribution of children currently on ART end of March 2009, by age group*
12.625.4
8.3 9.3 6.7
29.2
28.0
21.9 24.221.5
58.246.5
69.8 66.4 71.7
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Cote d`Ivoire Mozambique South Africa Tanzania Zambia
Countries
Perc
etag
e of
chi
ldre
n
0-1 year old 2-4 years old 5-14 years old
*not all sites in Mozambique and South Africa reported pediatric age breakdown information
Infant & Young Child (IYC) Strategy• Target setting – site specific
absolute numbers• Implementation approaches• Indicators for COC – PMTCT/C&T
linkages and integration• Emphasis on PMTCT• More focused monitoring &
feedback
IYC Strategy Indicators (Part 1), Q1 2009
Pregnant women identified as HIV
positive
Pregnant women who received
ARVs
Exposed infants who received
ARVs
Exposed infants who started on
cotrimoxazole at 6 weeks
Exposed infants tested for HIV
Exposed infants with a positive
test result
0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
45,000Nu
mbe
r of p
atien
ts
IYC Strategy Indicators (Part 2), Q1 2009
0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
45,000Nu
mbe
r of c
hild
ren
0100200
300400500600700800900
1000
Quarter
Num
ber o
f Site
s
Cote d'Ivoire Mozambique South Africa Tanzania Zambia
1. PMTCT is funded by CDC in CI, SA and Zambia. USAID funds PMTCT in TZ. In Mozambique, PMTCT funding is transitioning from USAID to CDC.
2. The above data is for all five PH countries to give a more thorough picture of services in PH countries
Number of EGPAF PMTCT Sites, Project HEART countries (2004-2009)
1. PMTCT is funded by CDC in CI, SA and Zambia. USAID funds PMTCT in TZ. In Mozambique, PMTCT funding is transitioning from USAID to CDC.
2. The above data is for all five PH countries to give a more thorough picture of services in PH countries
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
Eligible Women Counseled Tested Results
Cumulative 2007 2008
PMTCT Cascade A for Five Project HEART Countries (Eligible, counseling, testing, results)
1. PMTCT is funded by CDC in CI, SA and Zambia. USAID funds PMTCT in TZ. In Mozambique, PMTCT funding is transitioning from USAID to CDC.
2. The above data is for all five PH countries to give a more thorough picture of services in PH countries
0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
HIV Tested Positive Total HIV Positive Women ARV Infant ARV
Cumulative 2007 2008
PMTCT Cascade B for Five Project HEART Countries (HIV+, Women ARV, Infant ARV)
Hope for the Future
• Greater focus by donors on health system strengthening
• Intensive work toward transition in each Project HEART country including local capacity building
• Increasing funding for increasing access to PMTCT and Improving the PMTCT cascade
• Increasing the identification, enrollment and retention of children in care and treatment
• Improving the quality of care in each supported site
CÔTE D’IVOIRE• Anna Likos and CDC/CI• MOH CI• Joseph Essombo, Anthony
Tanoh, Diby Brou Charles, Joseph Kouakou and the EGPAF/CI team
EGPAF U.S.• Georgette Adjorlolo-
Johnson• Nicole Buono• Elizabeth Flanagan• Nick Hellmann• Trish Karlin• Stephen Lee• Richard Marlink• Rose McCullough• Sara Pacque-Margolis• Mposo Ntumbanzondo• Shobana Ramachandran• Penny Smith• Allison Spensley• Tara Suntoke• Andrea Wahl• Cathy Wilfert• Sue Willard
MOZAMBIQUE• Lisa Nelson and CDC/Moz• MOH Moz• Nancy Fitch, Cathrien
Alons, Esmeralda Karajeanes, Alex Boon, Etelvina Mbalane and the EGPAF/Moz team
SOUTH AFRICA• Thurma Goldman, Celicia
Serenata, and CDC/SA• DOH SA• Kuku Appiah, Marriam
Mangochi, Pumla Lupondwana and the EGPAF/SA team
TANZANIA• John Vertifeuille and
CDC/TZ• MOH TZ• Anja Giphart, Werner
Schimana, Jeroen van Padt Bosch, Aisa Muya and the EGPAF/TZ team
ZAMBIA• Larry Marum and
CDC/Zam• MOH Zambia• Susan Strasser and the
EGPAF/Zambia team• Jeff Stringer, Elizabeth
Stringer, Carolyn Bolton, Stewart Reid and the entire CIDRZ team
PARTNERSBaylor• Mark Kline• Meg Ferris
John Snow International• Andrew Fullem• Lisa Hirschhorn University of CA, San Francisco• Diane Havlir• Royce Lin• Oliver Bacon
CDC• Tedd Ellerbrock• Louise Perry• Diane Flournoy• Bud Bowen• Janna Brooks• CDC Staff in Côte d’Ivoire Mozambique, South Africa Tanzania, Zambia
……..AND ALL OF OUR PATIENTS, PARTNERS, STAFF AND DONORS
Acknowledgements